Inflammatory cardiomyopathies encompass a heterogeneous spectrum of disorders characterized by myocardial inflammation, including but not limited to myocarditis–which may be infectious, autoimmune, or drug/toxin-induced–cardiac sarcoidosis, and cardiac transplant rejection. Despite advances in diagnosis and management, these conditions remain a significant cause of left ventricular dysfunction, heart failure, arrhythmias, and cardiovascular mortality worldwide. Diagnosis is often challenging due to their patchy myocardial involvement and diverse clinical presentations. In this article, we will explore the current role of multimodality imaging in the evaluation of inflammatory cardiomyopathies– with a focus on myocarditis, identify existing knowledge gaps, and highlight future directions.